Cargando…
585. Safety of Pfizer-BioNtech COVID-19 Vaccine in Healthcare Workers, Singapore
BACKGROUND: On 14 December 2020, the Pfizer-BioNTech coronavirus disease 2019 (COVID-19) vaccine was granted emergency use authorization in Singapore. Healthcare workers (HCW) were prioritized to receive the vaccine. We aim to investigate the side effects and risk factors for allergic reactions in o...
Autores principales: | Kam, Kai-Qian, Yung, Chee Fu, Chong, Chia Yin, Li, Jia hui, Nadua, Karen Donceras, Tan, Natalie W, Thoon, Koh Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644355/ http://dx.doi.org/10.1093/ofid/ofab466.783 |
Ejemplares similares
-
Epidemiologic trends in Kawasaki disease during coronavirus disease-19 in Singapore
por: Yung, Chee Fu, et al.
Publicado: (2020) -
Adverse Events with the Pfizer-BioNTech COVID-19 Vaccine among Korean Healthcare Workers
por: Im, Jae Hyoung, et al.
Publicado: (2021) -
Myocarditis with Pfizer-BioNTech's COVID-19 vaccine in Israel
Publicado: (2021) -
Thrombocytopenia with Pfizer-BioNTech or Moderna COVID-19 vaccines
Publicado: (2021) -
Pfizer-BioNTech COVID-19 vaccine safe in children
Publicado: (2022)